• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

35
13
11
10
4

COUNTRY

11
2
1
1
1

CATEGORIES

  • 110
  • 96
  • 39
  • 37
  • 33
  • 27
  • 13
  • 11
  • 9
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

90
170
318
371

PUBLISHED

4
27
92
371

PRODUCT TYPE

272
98
1

Search "Alzheimer Disease Therapy Area Pipeline Report" returned 371 results.

Alzheimer's Disease - Pipeline Review, H2 2014

Alzheimer's Disease - Pipeline Review, H2 2014 Summary This, ‘Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast – Global Analysis

Alzheimer's disease drug market is on the curvature stage Since 2003, there is not any single “magic bullet” launched in the market to prevent or cure it However, all current marketed products are going...

December 2013
FROM
Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022 Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022 - Product Thumbnail Image

Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022

Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Aricept global...

April 2012
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

July 2015
FROM

Alzheimer's Disease - Pipeline Review, H1 2014

Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This...

February 2014
FROM

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015 Summary This, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Dementia...

April 2015
FROM
AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022 AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022 - Product Thumbnail Image

AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022

AAB-001 (bapineuzumab) (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “AAB-001 (bapineuzumab) (Alzheimer’s disease) – Analysis and Forecasts to...

April 2012
FROM
Gammagard Liquid (Alzheimer's disease) - Analysis and Forecasts to 2022 Gammagard Liquid (Alzheimer's disease) - Analysis and Forecasts to 2022 - Product Thumbnail Image

Gammagard Liquid (Alzheimer's disease) - Analysis and Forecasts to 2022

Gammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Gammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides...

April 2012
FROM
Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022 Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022 - Product Thumbnail Image

Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022

Namenda (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Namenda (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Namenda global...

April 2012
FROM
LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022 LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022 - Product Thumbnail Image

LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022

LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides LY2062430...

April 2012
FROM

US CNS Disorders Drug Pipeline Insight 2014

The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. The numbers of CNS disorders have increased at an alarming rate, while the available...

August 2014
FROM

Proteome Sciences Plc (PRM) - Product Pipeline Analysis, 2013 Update

Summary Proteome Sciences Plc (Proteome Sciences) is a protein biomarker company. The company delivers content for personalized medicine in different areas such as biomarker assays, biomarker services,...

July 2013
FROM
Nitric Oxide - Therapeutics, Markets and Companies Nitric Oxide - Therapeutics, Markets and Companies - Product Thumbnail Image

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

July 2015
FROM

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014 Summary This, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Dementia...

August 2014
FROM

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview...

March 2014
FROM

Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies

This report provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection,...

February 2011
FROM

Amarantus Bioscience Holdings, Inc. (AMBS) - Product Pipeline Analysis, 2013 Update

Summary Amarantus Bioscience Holdings, Inc. (Amarantus BioScience) is a biotechnology company. The company discovers and develops treatments and diagnostics for diseases associated with neurodegeneration...

August 2013
FROM

Alzheimer's Drugs Market, 2012 - 2017

Alzheimer's disease is a neurodegenerative disease of the brain which leads to loss of memory and cognitive functions With ageing world population, the number of patients suffering from Alzheimer's...

May 2013
FROM

Global Alzheimer's Drugs Market 2014-2018

Alzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65...

June 2014
FROM

PharmaPoint: Alzheimer's Disease - China Drug Forecast and Market Analysis to 2022

PharmaPoint: Alzheimer’s Disease - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Alzheimer’s Disease - China Drug Forecast and...

July 2013
FROM
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.